Research priorities and infrastructure needs of the family smoking prevention and tobacco control act: Science to inform FDA policy

Scott Leischow, Mitch J.D. Zeller, Cathy L. Backinger

Research output: Contribution to journalEditorial

15 Citations (Scopus)

Abstract

Introduction: A new law in the United States gives the Food and Drug Administration (FDA) wide latitude to regulate tobacco products for the first time. Given the need for science to serve as a foundation for FDA actions, it is critical that a scientific review of the literature relevant to the proposed legislation be undertaken by experts in the field of nicotine and tobacco research in order to develop research priorities. Methods: This paper describes an initiative that was implemented to identify research opportunities under "The Family Smoking Prevention and Tobacco Control Act" and summarizes the conclusions and future directions derived from that initiative. Results: Multiple research and surveillance needs were identified, such as characterization of biomarkers and increased analysis of risk perception. It was also recognized that science will play a critical role in policy determinations such as what constitutes "substantial equivalence" and that there will be considerable infrastructure needs (e.g., laboratories for product testing). Conclusions: Science must drive FDA's decision making regarding tobacco regulation. This article provides a summary of research opportunities identified through literature reviews related to various provisions of the new law. However, the science required by the law requires a transdisciplinary approach because of its complexity, so one of the challenges facing the FDA will be to connect the silos of research in recognition that the "system" of tobacco regulation is greater than the sum of its parts.

Original languageEnglish (US)
Pages (from-to)1-6
Number of pages6
JournalNicotine and Tobacco Research
Volume14
Issue number1
DOIs
StatePublished - Jan 3 2012

Fingerprint

United States Food and Drug Administration
Smoking
Research
Tobacco
Nicotine
Legislation
Tobacco Products
Decision Making
Biomarkers

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health

Cite this

Research priorities and infrastructure needs of the family smoking prevention and tobacco control act : Science to inform FDA policy. / Leischow, Scott; Zeller, Mitch J.D.; Backinger, Cathy L.

In: Nicotine and Tobacco Research, Vol. 14, No. 1, 03.01.2012, p. 1-6.

Research output: Contribution to journalEditorial

@article{b88a2578615149f89758aa7c71bbce30,
title = "Research priorities and infrastructure needs of the family smoking prevention and tobacco control act: Science to inform FDA policy",
abstract = "Introduction: A new law in the United States gives the Food and Drug Administration (FDA) wide latitude to regulate tobacco products for the first time. Given the need for science to serve as a foundation for FDA actions, it is critical that a scientific review of the literature relevant to the proposed legislation be undertaken by experts in the field of nicotine and tobacco research in order to develop research priorities. Methods: This paper describes an initiative that was implemented to identify research opportunities under {"}The Family Smoking Prevention and Tobacco Control Act{"} and summarizes the conclusions and future directions derived from that initiative. Results: Multiple research and surveillance needs were identified, such as characterization of biomarkers and increased analysis of risk perception. It was also recognized that science will play a critical role in policy determinations such as what constitutes {"}substantial equivalence{"} and that there will be considerable infrastructure needs (e.g., laboratories for product testing). Conclusions: Science must drive FDA's decision making regarding tobacco regulation. This article provides a summary of research opportunities identified through literature reviews related to various provisions of the new law. However, the science required by the law requires a transdisciplinary approach because of its complexity, so one of the challenges facing the FDA will be to connect the silos of research in recognition that the {"}system{"} of tobacco regulation is greater than the sum of its parts.",
author = "Scott Leischow and Zeller, {Mitch J.D.} and Backinger, {Cathy L.}",
year = "2012",
month = "1",
day = "3",
doi = "10.1093/ntr/ntr057",
language = "English (US)",
volume = "14",
pages = "1--6",
journal = "Nicotine and Tobacco Research",
issn = "1462-2203",
publisher = "Oxford University Press",
number = "1",

}

TY - JOUR

T1 - Research priorities and infrastructure needs of the family smoking prevention and tobacco control act

T2 - Science to inform FDA policy

AU - Leischow, Scott

AU - Zeller, Mitch J.D.

AU - Backinger, Cathy L.

PY - 2012/1/3

Y1 - 2012/1/3

N2 - Introduction: A new law in the United States gives the Food and Drug Administration (FDA) wide latitude to regulate tobacco products for the first time. Given the need for science to serve as a foundation for FDA actions, it is critical that a scientific review of the literature relevant to the proposed legislation be undertaken by experts in the field of nicotine and tobacco research in order to develop research priorities. Methods: This paper describes an initiative that was implemented to identify research opportunities under "The Family Smoking Prevention and Tobacco Control Act" and summarizes the conclusions and future directions derived from that initiative. Results: Multiple research and surveillance needs were identified, such as characterization of biomarkers and increased analysis of risk perception. It was also recognized that science will play a critical role in policy determinations such as what constitutes "substantial equivalence" and that there will be considerable infrastructure needs (e.g., laboratories for product testing). Conclusions: Science must drive FDA's decision making regarding tobacco regulation. This article provides a summary of research opportunities identified through literature reviews related to various provisions of the new law. However, the science required by the law requires a transdisciplinary approach because of its complexity, so one of the challenges facing the FDA will be to connect the silos of research in recognition that the "system" of tobacco regulation is greater than the sum of its parts.

AB - Introduction: A new law in the United States gives the Food and Drug Administration (FDA) wide latitude to regulate tobacco products for the first time. Given the need for science to serve as a foundation for FDA actions, it is critical that a scientific review of the literature relevant to the proposed legislation be undertaken by experts in the field of nicotine and tobacco research in order to develop research priorities. Methods: This paper describes an initiative that was implemented to identify research opportunities under "The Family Smoking Prevention and Tobacco Control Act" and summarizes the conclusions and future directions derived from that initiative. Results: Multiple research and surveillance needs were identified, such as characterization of biomarkers and increased analysis of risk perception. It was also recognized that science will play a critical role in policy determinations such as what constitutes "substantial equivalence" and that there will be considerable infrastructure needs (e.g., laboratories for product testing). Conclusions: Science must drive FDA's decision making regarding tobacco regulation. This article provides a summary of research opportunities identified through literature reviews related to various provisions of the new law. However, the science required by the law requires a transdisciplinary approach because of its complexity, so one of the challenges facing the FDA will be to connect the silos of research in recognition that the "system" of tobacco regulation is greater than the sum of its parts.

UR - http://www.scopus.com/inward/record.url?scp=84855170277&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84855170277&partnerID=8YFLogxK

U2 - 10.1093/ntr/ntr057

DO - 10.1093/ntr/ntr057

M3 - Editorial

C2 - 22184581

AN - SCOPUS:84855170277

VL - 14

SP - 1

EP - 6

JO - Nicotine and Tobacco Research

JF - Nicotine and Tobacco Research

SN - 1462-2203

IS - 1

ER -